Australia's TGA proposes new requirements for heparin
This article was originally published in RAJ Devices
Executive Summary
Australia’s Therapeutic Goods Administration has proposed new requirements to ensure that the contaminant over-sulfated chondroitin sulfate (OSCS) is not present in the anticoagulant heparin1.